Baxter International Aktie
WKN: 853815 / ISIN: US0718131099
26.04.2017 13:26:16
|
Baxter Raises Financial Outlook - Quick Facts
(RTTNews) - Baxter International Inc. (BAX) announced, for full-year 2017, based on the strong first quarter, the company now expects sales growth of approximately 1 to 2 percent on a reported basis or 2 to 3 percent on a constant currency basis, and earnings from continuing operations, before special items, of $2.20 to $2.28 per share for the full year. Adjusting for the impact of generic cyclophosphamide competition and selected strategic product exits, Baxter expects underlying constant currency sales growth of approximately 4 to 5 percent.
For the second quarter, the company expects flat sales growth on a reported basis, or approximately 2 percent on a constant currency basis. Adjusting for the impact of generic cyclophosphamide competition and selected strategic product exits, Baxter expects underlying constant currency sales growth of approximately 3 percent. The company expects earnings from continuing operations, before special items, of $0.55 to $0.57 per share.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Baxter International Inc.mehr Nachrichten
Analysen zu Baxter International Inc.mehr Analysen
Aktien in diesem Artikel
Baxter International Inc. | 26,54 | -1,03% |
|